BIOFORCE NANOSCIENCES HOLDINGS, INC. Cash and Restricted Cash
BIOFORCE NANOSCIENCES HOLDINGS, INC. (BFNH) had Cash and Restricted Cash of $307 as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-10
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $307.00.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.35K.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $786.00.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $784.00.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $307.00 10-Q · filed 2026-08-10 |
| 2026-03-31 | $6.35K 10-Q · filed 2026-05-19 |
| 2025-12-31 | $786.00 10-Q · filed 2026-08-10 |
| 2025-09-30 | $784.00 10-Q · filed 2025-11-19 |
| 2025-06-30 | $905.00 10-Q · filed 2026-08-10 |
| 2025-03-31 | $13.80K 10-Q · filed 2026-05-19 |
| 2024-12-31 | $862.00 10-Q · filed 2026-08-10 |
| 2024-09-30 | $1.64K 10-Q · filed 2025-11-19 |
| 2024-06-30 | $667.00 10-Q · filed 2025-08-11 |
| 2024-03-31 | $640.00 10-Q · filed 2025-05-13 |
| 2023-12-31 | $638.00 10-K · filed 2026-04-15 |
| 2023-09-30 | $686.00 10-Q · filed 2024-11-08 |
| 2023-06-30 | $654.00 10-Q · filed 2024-08-07 |
| 2023-03-31 | $686.00 10-Q · filed 2024-05-03 |
| 2022-12-31 | $734.00 10-K · filed 2025-04-08 |
| 2022-09-30 | $750.00 10-Q · filed 2023-11-03 |
| 2022-06-30 | $9.23K 10-Q · filed 2023-08-01 |
| 2022-03-31 | $11.11K 10-Q · filed 2023-05-09 |
| 2021-12-31 | $11.11K 10-K · filed 2024-04-01 |
| 2021-09-30 | $27.30K 10-Q · filed 2022-11-02 |
| 2021-06-30 | $27.30K 10-Q · filed 2022-07-27 |
| 2021-03-31 | $31.84K 10-Q · filed 2022-05-05 |
| 2020-12-31 | $39.87K 10-K · filed 2023-03-28 |